ACADIA Pharmaceuticals (NASDAQ:ACAD) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
ACADIA Pharmaceuticals missed estimated earnings by 16.67%, reporting an EPS of $-0.7 versus an estimate of $-0.6.
Revenue was up $8.91 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.03 which was followed by a 1.34% drop in the share price the next day.
Here's a look at ACADIA Pharmaceuticals's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.24 | -0.26 | -0.31 | -0.53 |
| EPS Actual | -0.27 | -0.09 | -0.27 | -0.42 |
| Revenue Estimate | 135.60M | 127.75M | 126.15M | 111.63M |
| Revenue Actual | 130.76M | 131.61M | 115.22M | 106.55M |
To track all earnings releases for ACADIA Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
